A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center

Tag: Knee replacement surgery

Xarelto (Rivaroxaban) – FDA Approved

Today the FDA approved the oral anticoagulant Xarelto (rivaroxaban) for DVT prevention in patients undergoing knee or hip replacement surgery. This is good news

July 1, 2011
Xarelto (Rivaroxaban) – FDA Approved

On July 1st, the FDA approved the oral blood thinner Xarelto (rivaroxaban) for the prevention of deep vein thrombosis (DVT) in patients undergoing knee or hip replacement surgery.

July 1, 2011

Tag: Knee replacement surgery

Xarelto (Rivaroxaban) – FDA Approved

Xarelto (Rivaroxaban) – FDA Approved